The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...

Scientists have discovered that the hypertension drug rilmenidine mimics the life-extending benefits of calorie restriction ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

Feeling uncomfortably swollen and nauseous isn't on anyone's Christmas list-but it's something millions of Britons end up ...

Food companies are already dealing with shifts in consumer tastes toward higher protein and smaller portions due to the ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy (R) pill, the first oral GLP-1 medicine for obesity in the US. (3) Wegovy (R) pill is used ...

The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

Major reforms to the justice system, including the abolition of the not proven verdict, will come into force on 1 January. Justice Secretary Angela Constance has laid regulations to bring the new law ...

A secret weapon that can lower cholesterol has been flying under the radar for more than 20 years. It’s called the portfolio diet—and it has been gaining followers, thanks to rising interest in ...

A 22 year old woman collapsed at her workplace in Trat and was rushed to the hospital late last night, December 3, after reportedly taking weight loss pills for over 10 months. Investigators suspect ...